Ir al contenido
Información para Aseguradoras
International services
Main Menu
Enlaces
  • Preguntas frecuentes
  • 01800 519 0175
  • +573208718677
Contáctenos
  • Preguntas frecuentes
  • 01800 519 0175
logo-colombiana-trasplantes-2024-blanco
Main Menu
  • Nosotros
    • Quiénes Somos
    • Historia
    • Nuestro Equipo
    • Instalaciones
    • Indicadores
    • Estados Financieros
    • Línea Ética
  • Servicios
    • Nacionales
    • Internacionales
  • Investigación
    • Centro de investigación
    • Grupo de investigación
    • Publicaciones
  • Educación
    • Centro de Artículos
    • Enfermedad renal
    • Enfermedad hepática
  • Donación
logo-colombiana-trasplantes-2024-blanco
Main Menu
  • Nosotros
    • Quiénes Somos
    • Historia
    • Nuestro Equipo
    • Instalaciones
    • Indicadores
    • Estados Financieros
    • Línea Ética
  • Servicios
    • Nacionales
    • Internacionales
  • Investigación
    • Centro de investigación
    • Grupo de investigación
    • Publicaciones
  • Educación
    • Centro de Artículos
    • Enfermedad renal
    • Enfermedad hepática
  • Donación
Donación y donante vivo

Safety and Intraoperative Results in Live Kidney Donors with Vascular Multiplicity After Hand-Assisted Laparoscopy Living Donor

  • febrero 10, 2017
Publicado en: Research and Reports in Urology – Internacional

Autores

  • Fernando Girón Luque, M.D., MEHP
  • Yenny Báez Suárez, M.D.
  • Andrea García López, M.D., MSc, Ph.D.

Instituciones

  1. Colombiana de Trasplantes, Bogotá, Colombia

Background and Purpose:

Vascular multiplicity is the most frequent anatomic variation in kidney donors. Despite concerns about risks, these allografts are increasingly used to overcome the shortage of kidney donors. The safety and clinical outcomes in living kidney donors were evaluated with vascular multiplicity after hand-assisted laparoscopic living donor nephrectomy (HALDN).

Patients and Methods:

Data from all living kidney donors who underwent HALDN from 2008 to 2021 was retrospectively reviewed. Patients were divided into two groups as single (SRV) and multiple renal vessels (MRV), and a comparative analysis was done. The primary outcomes include operating room time (ORT), days of hospital stay, estimated blood loss, complications, conversion, and re-operations.

Results:

MRV were present in 166 out of 612 donors (27.1%). Among those, 10 (1.6%) donors had simultaneous multiple arteries and veins. Additionally, the prevalence of artery and vein multiplicity was 21.8% (n = 134) and 3.5% (n = 22), respectively. Warm ischemia time was significantly different among the two groups but not clinically important. The number of conversions to open technique, the mean ORT, the median blood loss, and days of hospital stay were similar between the SRV and MRV groups, without significant differences. According to the modified Clavien-classification system, no differences were found in the complication rates between the two groups (p = 0.29). Complication rates were 3.3% and3.6% for the SRV and MRV groups, respectively.

Conclusion:

HALDN is a procedure with safe intraoperative results, even with vascular multiplicity. The presence of multiple renal arteries or veins has no negative impact on theoutcome of the donor after living donor nephrectomy

Keywords:

Anatomic variation; kidney transplant; laparoscopic nephrectomy; living kidney donors; vascular multiplicity

Palabras clave

anatomic variation | Kidney transplant | laparoscopic nephrectomy | Living Kidney Donors | vascular multiplicity
Ver documento
Donación y donante vivo

Safety and Intraoperative Results in Live Kidney Donors with Vascular Multiplicity After Hand-Assisted Laparoscopy Living Donor

  • febrero 10, 2017

Comparte en:

Download
anatomic variation, Kidney transplant, laparoscopic nephrectomy, Living Kidney Donors, vascular multiplicity
PrevAnteriorStrongyloides stercoralis; REPORTE DE UN CASO EN EL POST-TRASPLANTE RENAL
SiguienteHistoplasmosis diseminada y síndrome hemofagocítico en trasplante renal 2017Next

Datos de contacto

  • Línea gratuita de atención nacional:
    01 800 519 0 175
  • contactenos@colombianadetrasplantes.com
  • (57) 320 871 8677
  • Contacto del Programa de Donante Vivo:
    (57) 322 893 0725
    donantevivo@colombianadetrasplantes.com
Facebook Linkedin-in Instagram Youtube Tiktok

Información de Sedes

  • Sede principal - Bogotá
    Av. Cra. 30 # 47A-74
  • Puerto Colombia
    Cra 30, Corredor Universitario 1-850, Torre médica. Consultorio 307 y 308
  • Cali
    Edificio Vida. Calle 5D #38A - 35. Piso 2, local 23
  • Armenia
    Cra 12 No. 0-75. Consultorio 506, Clínica del Café

Enlaces rápidos

  • Contáctenos - PQRSF
  • Asociación de usuarios
  • Derechos y deberes de pacientes
  • Política de tratamiento de datos
  • Términos y condiciones
  • Trabaje con Nosotros

Servicios para empleados

  • Intranet
SUPERSALUD
Todos los derechos reservados © 2025 Colombiana de Trasplantes SAS
descarga la novena en tu celular

WhatsApp